Defrijet 250mg 10 Tablets

Babies: It is not applicable for babies. Lactating mother: It is safe to use during breastfeeding. Pregnancy: It is unsafe to use during pregnancy.
Limited studies have shown harmful effects on developing babies. Seek doctor advice before using this medication Driving: Defrijet tablet may cause side effects that could affect your ability to drive. Alcohol: It is unknown whether it is safe to consume alcohol with defrijet tablets.
Seek doctor advice before using this medication Kidney: Defrijet tablet is unsafe to use in patients with kidney disease. Seek doctor advice before using this medication. Liver: Defrijet tablet should be used in caution with patients suffering from liver disease.
You may require a dose adjustment. Seek doctor advice before using this medication..

Nausea Headache Vomiting Rash Abdominal pain Constipation Itching Abdominal distension Diarrhoea.

Defrijet tablet is a chelating agent. It works by binding to excess iron in the blood and removing it from the body through the stool.
.

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Defrijet tablet is used to remove excess iron from the body • Inform your doctor if you experience upper stomach pain, clay-coloured stools, or yellowing of your skin and the whites of your eyes • Take an adequate amount of water while taking defrijet tablet • Defrijet tablets may cause side effects that could affect your ability to drive • If you are taking any, antacid take them 2 hours before or after defrijet tablet • Inform your doctor if you have any liver and kidney problems.

Serious • Defrijet + Tucatinib: Concurrent use of both drugs leads to an increase in the level or effect of tucatinib Monitor closely • Defrijet + Alfentanil: Concurrent use of both drugs leads to a decrease in the level or effect of alfentanil by affecting hepatic/intestinal enzyme cyp3a4 metabolism • Defrijet + Alprazolam: Concurrent use of both drugs leads to a decrease in the level or effect of alprazolam by affecting hepatic/intestinal enzyme cyp3a4 metabolism Minor • Defrijet + Aprepitant: Concurrent use of both drugs leads to a decrease in the level or effect of aprepitant by affecting hepatic/intestinal enzyme cyp3a4 metabolism • Defrijet + Cevimeline: Concurrent use of both drugs leads to a decrease in the level or effect of cevimeline by affecting hepatic/intestinal enzyme cyp3a4 metabolism • Defrijet + Docetaxel: Concurrent use of both drugs leads to a decrease in the level or effect of docetaxel by affecting.